Stockreport

EXCLUSIVE: Alzamend Neuro Submits IND For Phase IIA Trial Of Next-Gen Lithium Candidate In Major Depressive Disorder [Yahoo! Finance]

Alzamend Neuro, Inc.  (ALZN) 
PDF Alzamend Neuro is a clinical-stage biopharmaceutical company focused on developing novel products for treating Alzheimer's, BD, MDD, and PTSD. Lithium, although not F [Read more]